Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

1.2K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

5.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

807
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
807

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus recommendations for the integration of critical care pharmacists on intensive care unit teams: Endorsed by the American Association of Critical-Care Nurses, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine.

Journal of the American College of Clinical Pharmacy : JACCP·2025
Same author

Working With Chronic Health Conditions: A Case for More Proactive Support.

Workplace health & safety·2024
Same author

Exploring the Utility and Fairness of a Multi-institutional Situational Judgment Test.

American journal of pharmaceutical education·2024
Same author

From symptoms to solutions: A structured approach to alleviating burnout among critical care pharmacists.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2024
Same author

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage.

JAMA neurology·2024
Same author

An Exploratory Qualitative Study of Student Pharmacist Perspectives on Leadership.

American journal of pharmaceutical education·2024
Same journal

Lung Fluid Monitoring: A Novel Pulmonary Health Assessment Framework for CHF Patients.

Current cardiology reviews·2026
Same journal

AI-driven Approach to Treat Acute Coronary Syndrome: A Review on Integration of AlphaFold in Cardiovascular Genomics.

Current cardiology reviews·2026
Same journal

Cardiovascular Risk Assessment: A Review of Current Models and Emerging Determinants, including Biomarkers, Genetics, and Artificial Intelligence.

Current cardiology reviews·2026
Same journal

Decoding the Genetic Architecture of Acute Coronary Syndrome: A Review on Integrated Medical Modeling.

Current cardiology reviews·2026
Same journal

Prognostic Value of Ceramide-Based Lipid Scores in Cardiovascular Disease and Heart Failure: Insights From CERT1, CERT2, and Ceramide Ratios.

Current cardiology reviews·2026
Same journal

Sudden Arrhythmic Death Presenting with Convulsive Syncope In A Young Man With Severe Coronary Atherosclerosis And Hyperthyroidism: A Case Report.

Current cardiology reviews·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

A Modified Technique for Transverse Aortic Constriction in Mice
04:52

A Modified Technique for Transverse Aortic Constriction in Mice

Published on: August 18, 2022

5.3K

Stage A: can heart failure be prevented?

Ilya M Danelich, Brent N Reed, Carla A Sueta1

  • 1Clinical Pharmacist, Department of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. danelich.ilya@mayo.edu.

Current Cardiology Reviews
|November 21, 2013
PubMed
Summary
This summary is machine-generated.

Effective blood pressure management significantly lowers heart failure risk. Lowering systolic blood pressure by 5 mm Hg reduces heart failure development by 24%, with thiazide diuretics being most effective for hypertension.

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.1K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Related Experiment Videos

Last Updated: May 5, 2026

A Modified Technique for Transverse Aortic Constriction in Mice
04:52

A Modified Technique for Transverse Aortic Constriction in Mice

Published on: August 18, 2022

5.3K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.1K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Background:

  • Heart failure (HF) is a widespread epidemic with high morbidity and mortality.
  • Over 5 million Americans and 1-2% globally are affected by heart failure.
  • Observational studies indicate lifestyle factors can mitigate HF risk.

Purpose of the Study:

  • To review the most effective strategies for preventing heart failure development and progression.
  • To evaluate the impact of blood pressure control on heart failure outcomes.
  • To identify optimal pharmacologic agents for heart failure risk reduction.

Main Methods:

  • Analysis of clinical trials and observational studies focusing on heart failure prevention and progression.
  • Review of data on blood pressure reduction and its correlation with HF incidence.
  • Evaluation of different antihypertensive medication classes for their efficacy in preventing HF.

Main Results:

  • A 5 mm Hg reduction in systolic blood pressure decreases HF risk by 24%.
  • Thiazide diuretics are highly effective for hypertension-related HF prevention.
  • ACE inhibitors and ARBs are recommended for patients with atherosclerosis, diabetes, or CKD.
  • Beta-blockers are less effective as monotherapy; cardioselective agents are preferred.
  • Non-dihydropyridine calcium channel blockers and alpha blockers should be avoided for HF risk reduction.

Conclusions:

  • Blood pressure treatment is the paramount strategy for preventing heart failure.
  • Specific antihypertensive medications offer varying degrees of benefit in HF prevention.
  • Tailoring pharmacologic therapy based on patient comorbidities is crucial for effective HF risk management.